March 7 (Reuters) - Kazia Therapeutics Ltd (KZA) :
- ENTERED INTO COLLABORATION WITH AUSTRALIAN AND NEW ZEALAND CHILDREN'S HAEMATOLOGY / ONCOLOGY GROUP
- COLLABORATION FOR PHASE II CLINICAL STUDY EXAMINING PAXALISIB IN CHILDREN WITH ADVANCED SOLID TUMOURS, INCLUDING BRAIN TUMOURS
News: KZA Kazia Therapeutics Enters Collaboration With Australian And NZ Children's...
Add to My Watchlist
What is My Watchlist?